MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
UroGen Pharma Ltd. Ordinary Shares

URGN

#2066
UroGen Pharma Ltd. Ordinary Shares
21.7000
+4.28%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
21.7000
21.7000
Intervallo Annuale
18.1200
29.9800
Variazione giornaliera
+4.28%
Variazione Mensile
-0.60%
Variazione di 6 mesi
+14.21%
Variazione Annuale
+14.21%
Chiusura Precedente
20.8100
Open
21.7000
Bid
Ask
Low
21.7000
High
21.7000
Volume
74
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. URGN
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20202021202220232024

Notizie

Investing Investing
URGN
2026.02.05
UroGen Pharma: CMO Schoenberg verkauft Aktien im Wert von 145.000 US-Dollar
Investing Investing
URGN
2026.02.05
UroGen Pharma CMO Schoenberg sells $145k in shares
Seeking Alpha Seeking Alpha
ENGN JNJ URGN RLMD IBRX
2025.12.26
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
Seeking Alpha Seeking Alpha
TSLA ARQT MDGL TARS KRYS
2025.12.22
2025 Performance Review And Future Strategy
Investing Investing
URGN
2025.11.19
Urogen Pharma-Aktie erreicht 52-Wochen-Hoch bei 25,2 USD
Investing Investing
URGN
2025.11.19
Urogen Pharma Ltd stock hits 52-week high at 25.2 USD
Investing Investing
URGN
2025.11.11
UroGen Pharma at Guggenheim Conference: Strategic Insights into UGN-102 Launch
Investing Investing
URGN
2025.11.07
Urogen Pharma stock hits 52-week high at 23.66 USD
Seeking Alpha Seeking Alpha
URGN
2025.11.07
UroGen Pharma Ltd. (URGN) Q3 2025 Earnings Call Transcript
Investing Investing
URGN
2025.11.06
Positive Studiendaten beflügeln Aktie von UroGen Pharma
Investing Investing
URGN
2025.11.06
UroGen Pharma stock jumps after positive Phase 3 trial results
Investing Investing
URGN
2025.11.06
UroGen Pharma stock price target raised to $30 from $25 at D. Boral Capital

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd